This announcement is a separate document:
賽生藥業：非執行董事辭任及撤回2023年股東週年大會的第3(c)號普通決議案
SCICLONE PHARMA: RETIREMENT OF NON-EXECUTIVE DIRECTOR AND WITHDRAWAL OF ORDINARY RESOLUTION NO.3(C) AT THE 2023 ANNUAL GENERAL MEETING
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.